Search by PDB author

COMBINED CRYSTALLOGRAPHIC REFINEMENT AND ENERGY MINIMIZATION OF RUBREDOXIN AT 1.2 ANGSTROM RESOLUTION
分子名称:	FE (III) ION, RUBREDOXIN
著者	Watenpaugh, K.D.
登録日	1984-10-15
公開日	1985-04-01
最終更新日	2024-03-06
実験手法	X-RAY DIFFRACTION (1.2 Å)
主引用文献	Combined Crystallographic Refinement and Energy Minimization of Rubredoxin at 1.2 Angstrom Resolution To be Published

4RXN

CRYSTALLOGRAPHIC REFINEMENT OF RUBREDOXIN AT 1.2 ANGSTROMS RESOLUTION
分子名称:	FE (III) ION, RUBREDOXIN
著者	Watenpaugh, K.D, Sieker, L.C, Jensen, L.H.
登録日	1984-10-15
公開日	1985-04-01
最終更新日	2024-02-28
実験手法	X-RAY DIFFRACTION (1.2 Å)
主引用文献	Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution. J.Mol.Biol., 138, 1980

1FX1

A CRYSTALLOGRAPHIC STRUCTURAL STUDY OF THE OXIDATION STATES OF DESULFOVIBRIO VULGARIS FLAVODOXIN
分子名称:	FLAVIN MONONUCLEOTIDE, FLAVODOXIN
著者	Watenpaugh, K.D, Sieker, L.C, Jensen, L.H.
登録日	1984-10-15
公開日	1985-01-02
最終更新日	2023-07-26
実験手法	X-RAY DIFFRACTION (2 Å)
主引用文献	A Crystallographic Structural Study of the Oxidation States of Desulfovibrio Vulgaris Flavodoxin Flavins and Flavoproteins, 1976

6UPJ

HIV-2 PROTEASE/U99294 COMPLEX
分子名称:	6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE, HIV-2 PROTEASE
著者	Watenpaugh, K.D, Mulichak, A.M, Finzel, B.C.
登録日	1996-12-10
公開日	1997-04-21
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (2.34 Å)
主引用文献	Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors. J.Med.Chem., 38, 1995

7UPJ

HIV-1 PROTEASE/U101935 COMPLEX
分子名称:	HIV-1 PROTEASE, N-(3-CYCLOPROPYL(5,6,7,8,9,10-HEXAHYDRO-2-OXO-2H-CYCLOOCTA[B]PYRAN-3-YL)METHYL)PHENYLBENZENSULFONAMIDE
著者	Watenpaugh, K.D, Janakiraman, M.N.
登録日	1996-12-05
公開日	1997-04-21
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (2 Å)
主引用文献	Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. J.Med.Chem., 40, 1997

5UPJ

HIV-2 PROTEASE/U99283 COMPLEX
分子名称:	5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE, HIV-2 PROTEASE
著者	Watenpaugh, K.D, Mulichak, A.M, Finzel, B.C.
登録日	1996-12-10
公開日	1997-04-21
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (2.3 Å)
主引用文献	Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors. J.Med.Chem., 38, 1995

3UPJ

HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U096333 [4-HYDROXY-3-[1-(PHENYL)PROPYL]-7-METHOXYCOUMARIN]
分子名称:	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE, HIV-2 PROTEASE
著者	Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
登録日	1996-03-04
公開日	1996-10-14
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (2.5 Å)
主引用文献	Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J.Med.Chem., 38, 1995

2UPJ

HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER)
分子名称:	HIV-1 PROTEASE, [2-(3-{[6-(1-BENZYL-PROPYL)-4-HYDROXY-2-OXO-2H-PYRAN-3-YL]-CYCLOPROPYL-METHYL}-PHENYLCARBAMOYL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
著者	Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
登録日	1996-03-04
公開日	1996-10-14
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (3 Å)
主引用文献	Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J.Med.Chem., 38, 1995

1HPO

HIV-1 PROTEASE TRIPLE MUTANT/U103265 COMPLEX
分子名称:	4-CYANO-N-(3-CYCLOPROPYL(5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-2-OXO-CYCLOOCTA[B]PYRAN-3-YL)METHYL)PHENYL BENZENSULFONAMIDE, HIV-1 PROTEASE
著者	Watenpaugh, K.D, Janakiraman, M.N.
登録日	1996-12-10
公開日	1997-04-21
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (2.5 Å)
主引用文献	Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. J.Med.Chem., 40, 1997

4UPJ

HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 PROTEASE MUTANT WITH LYS 57 REPLACED BY LEU (K57L) COMPLEX WITH U097410 [4-HYDROXY-3-[1-[3-[[[[(TERT-BUTYLOXYCARBONYL) AMINOMETHYL]CARBONYL]AMINO]PHENYL]PROPYL]COUMARIN
分子名称:	({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER, HIV-2 PROTEASE
著者	Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
登録日	1996-03-04
公開日	1996-10-14
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (1.9 Å)
主引用文献	Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J.Med.Chem., 38, 1995

1UPJ

HIV-1 PROTEASE COMPLEX WITH U095438 [3-[1-(4-BROMOPHENYL) ISOBUTYL]-4-HYDROXYCOUMARIN
分子名称:	3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE, HIV-1 PROTEASE
著者	Watenpaugh, K.D, Mulichak, A.M, Janakiraman, M.N.
登録日	1996-03-04
公開日	1996-10-14
最終更新日	2024-04-03
実験手法	X-RAY DIFFRACTION (2.22 Å)
主引用文献	Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J.Med.Chem., 38, 1995

1QB0

HUMAN CDC25B CATALYTIC DOMAIN
分子名称:	BETA-MERCAPTOETHANOL, CHLORIDE ION, PROTEIN (M-PHASE INDUCER PHOSPHATASE 2 (CDC25B)), ...
著者	Watenpaugh, K.D, Reynolds, R.A.
登録日	1999-04-29
公開日	2000-04-29
最終更新日	2018-02-28
実験手法	X-RAY DIFFRACTION (1.91 Å)
主引用文献	Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J.Mol.Biol., 293, 1999

1CWT

HUMAN CDC25B CATALYTIC DOMAIN WITH METHYL MERCURY
分子名称:	CDC25 B-TYPE TYROSINE PHOSPHATASE, CHLORIDE ION, METHYL MERCURY ION, ...
著者	Watenpaugh, K.D, Reynolds, R.A.
登録日	1999-08-26
公開日	2000-08-30
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (2.3 Å)
主引用文献	Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J.Mol.Biol., 293, 1999

1CWS

HUMAN CDC25B CATALYTIC DOMAIN WITH TUNGSTATE
分子名称:	BETA-MERCAPTOETHANOL, CDC25 B-TYPE TYROSINE PHOSPHATASE, CHLORIDE ION, ...
著者	Watenpaugh, K.D, Reynolds, R.A, Chidester, C.G.
登録日	1999-08-26
公開日	2000-08-30
最終更新日	2011-07-13
実験手法	X-RAY DIFFRACTION (2 Å)
主引用文献	Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J.Mol.Biol., 293, 1999

1D4Y

HIV-1 PROTEASE TRIPLE MUTANT/TIPRANAVIR COMPLEX
分子名称:	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, PROTEIN (HIV-1 PROTEASE)
著者	Watenpaugh, K.D, Janakiraman, M.N.
登録日	1999-10-06
公開日	1999-10-13
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (1.97 Å)
主引用文献	Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J.Med.Chem., 39, 1996

1D4S

HIV-1 PROTEASE V82F/I84V DOUBLE MUTANT/TIPRANAVIR COMPLEX
分子名称:	N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, PROTEIN (HIV-1 PROTEASE)
著者	Watenpaugh, K.D, Janakiraman, M.N.
登録日	1999-10-05
公開日	1999-10-12
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (2.5 Å)
主引用文献	Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J.Med.Chem., 39, 1996

1CWR

HUMAN CDC25B CATALYTIC DOMAIN WITHOUT ION IN CATALYTIC SITE
分子名称:	BETA-MERCAPTOETHANOL, PROTEIN (M-PHASE INDUCER PHOSPHATASE 2 (CDC25B)), SULFATE ION
著者	Watenpaugh, K.D, Reynolds, R.A, Chidester, C.G.
登録日	1999-08-26
公開日	2000-08-28
最終更新日	2023-12-06
実験手法	X-RAY DIFFRACTION (2.1 Å)
主引用文献	Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J.Mol.Biol., 293, 1999

1JSV

The structure of cyclin-dependent kinase 2 (CDK2) in complex with 4-[(6-amino-4-pyrimidinyl)amino]benzenesulfonamide
分子名称:	4-[(6-AMINO-4-PYRIMIDINYL)AMINO]BENZENESULFONAMIDE, CELL DIVISION PROTEIN KINASE 2
著者	Watenpaugh, K.D, Kelley, L.C.
登録日	2001-08-19
公開日	2001-08-29
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (1.96 Å)
主引用文献	The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism J.Biol.Chem., 276, 2001

5FX2

COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
分子名称:	FLAVIN MONONUCLEOTIDE, FLAVODOXIN
著者	Watt, W, Watenpaugh, K.D.
登録日	1991-10-17
公開日	1993-10-31
最終更新日	2024-03-13
実験手法	X-RAY DIFFRACTION (1.9 Å)
主引用文献	Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J.Mol.Biol., 218, 1991

4FX2

COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
分子名称:	FLAVIN MONONUCLEOTIDE, FLAVODOXIN
著者	Watt, W, Watenpaugh, K.D.
登録日	1991-10-17
公開日	1993-10-31
最終更新日	2024-02-28
実験手法	X-RAY DIFFRACTION (1.9 Å)
主引用文献	Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J.Mol.Biol., 218, 1991

3FX2

COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
分子名称:	FLAVIN MONONUCLEOTIDE, FLAVODOXIN
著者	Watt, W, Watenpaugh, K.D.
登録日	1991-10-17
公開日	1993-10-31
最終更新日	2024-02-21
実験手法	X-RAY DIFFRACTION (1.9 Å)
主引用文献	Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J.Mol.Biol., 218, 1991

2FX2

COMPARISON OF THE CRYSTAL STRUCTURES OF A FLAVODOXIN IN ITS THREE OXIDATION STATES AT CRYOGENIC TEMPERATURES
分子名称:	FLAVIN MONONUCLEOTIDE, FLAVODOXIN
著者	Watt, W, Watenpaugh, K.D.
登録日	1991-10-17
公開日	1993-10-31
最終更新日	2024-02-14
実験手法	X-RAY DIFFRACTION (1.9 Å)
主引用文献	Comparison of the crystal structures of a flavodoxin in its three oxidation states at cryogenic temperatures. J.Mol.Biol., 218, 1991

2HPF

COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
分子名称:	HIV-2 PROTEASE, UNIDENTIFIED PEPTIDE FRAGMENT
著者	Mulichak, A.M, Watenpaugh, K.D.
登録日	1994-09-21
公開日	1994-10-15
最終更新日	2024-02-14
実験手法	X-RAY DIFFRACTION (3 Å)
主引用文献	Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure To be Published

2HPE

COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE
分子名称:	HIV-2 PROTEASE, UNIDENTIFIED PEPTIDE FRAGMENT
著者	Mulichak, A.M, Watenpaugh, K.D.
登録日	1994-09-21
公開日	1994-10-15
最終更新日	2024-02-14
実験手法	X-RAY DIFFRACTION (2 Å)
主引用文献	Comparison of the Structures of HIV-2 Protease Complexes in Three Crystal Space Groups with an HIV-1 Protease Complex Structure To be Published

1I1B

CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
分子名称:	INTERLEUKIN-1 BETA
著者	Finzel, B.C, Watenpaugh, K.D, Einspahr, H.M.
登録日	1989-12-05
公開日	1990-01-15
最終更新日	2024-02-07
実験手法	X-RAY DIFFRACTION (2 Å)
主引用文献	Crystal structure of recombinant human interleukin-1 beta at 2.0 A resolution. J.Mol.Biol., 209, 1989

12 >

全ヒット件数:	43
表示件数:	25
表示順	関連性が高い順